连续流左心室辅助装置患者撤除方案的结果
该回顾性分析评估了一套标准化超声心动图评估及有创技术用于筛选适合撤除连续流左心室辅助装置(CF-LVAD)的患者。撤除后中位随访9.74个月,生存率93%。结论认为该方案可行且安全,所应用标准能良好筛选出撤除后获得持续中期心肌恢复的患者。
要点
- 撤除评估纳入标准包括临床稳定、LVAD支持>6个月、体力活动、正常超声心动图及不超过轻度瓣膜病和主动脉瓣开放。
- 第三步在CF-LVAD停泵及球囊导管闭塞流出道 graft 下行右心导管,撤除标准为肺动脉压正常及肺毛细血管楔压<16 mmHg。
- 撤除组与非撤除组基线PCWP分别为8.5(2.8)mmHg与10.6(2.8)mmHg(p=0.105),闭塞流出道后分别升至10.9(3.0)mmHg与20.8(4.9)mmHg(p<0.001)。
核心结论
- 该撤除方案可行且安全,所应用标准能为LVAD撤除后持续中期心肌恢复提供良好的患者筛选。
研究设计与样本
- 回顾性分析,评估标准化超声心动图评估及有创技术用于CF-LVAD撤除的患者筛选。
主要发现
- 撤除组基线PCWP为8.5(2.8)mmHg,非撤除组为10.6(2.8)mmHg(p=0.105)。
- 流出道闭塞下PCWP在撤除组升至10.9(3.0)mmHg,非撤除组升至20.8(4.9)mmHg,非撤除组显著更高(p<0.001)。
- 撤除后中位随访9.74个月(四分位距4.3至20.60),生存率93%。
关键数值与推荐
- LVAD恢复评估纳入标准:临床稳定、LVAD支持>6个月、体力活动、正常超声心动图、不超过轻度瓣膜病及主动脉瓣开放。
- 第二步在CF-LVAD减泵和停泵条件下行超声心动图(PStopE)。
- 第三步对参数稳定者在CF-LVAD停泵及球囊导管闭塞流出道 graft 下行右心导管。
- 撤除标准为肺动脉压正常及肺毛细血管楔压<16 mmHg。
临床怎么用
- 对临床稳定且LVAD支持>6个月的CF-LVAD患者,可按本方案逐步行超声心动图及右心导管评估心肌恢复。
- 撤除决策可参考停泵及流出道闭塞下PCWP反应,非撤除组闭塞后PCWP显著更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this retrospective analysis we evaluated a standardized echocardiographic assessment and an invasive technique for patient selection for successful continuous-flow left ventricular assist device (CF-LVAD) explantation. METHODS: Inclusion criteria for LVAD recovery assessment were: clinically stable condition; LVAD support for >6 months; physical activity; normal echocardiography findings; and no more than mild valvular disease and aortic valve opening. In a second step, echocardiography was performed under CF-LVAD reduction and stop conditions (PStopE). In the third step, patients who presented with stable parameters underwent right heart catheterization under CF-LVAD stoppage and occlusion of the outflow graft with a balloon catheter. Criteria for explantation were normal pulmonary artery pressure and pulmonary capillary wedge pressure <16 mmHg. RESULTS: Thirty-three of 424 patients entered the second step of evaluation and 20 entered the third step. Fourteen presented positive results and the pump was successfully explanted. The PCWP at baseline was 8.5 (2.8) mmHg in the explantation group and 10.6 (2.8) mmHg in the non-explantation group (p = 0.105). It increased to 10.9 (3.0) mmHg vs 20.8 (4.9) mmHg under outflow graft occlusion. The wedge pressure was significantly higher in the non-explantation group (p < 0.001). Median duration of follow-up after explantation was 9.74 (interquartile range 4.3 to 20.60) months, with survival of 93%. CONCLUSIONS: The protocol presented is feasible and safe. The criteria applied provide good patient selection for sustained mid-term myocardial recovery after LVAD explantation.
引用
- Knierim J, Heck R, Pieri M, et al. Outcomes from a recovery protocol for patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018. PMID: 30503053. doi:10.1016/j.healun.2018.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。